
Nesa Medtech Receives FDA Clearance for Its Fibroid Mapping Reviewer Application
Nesa Medtech advises their novel SaMD technology generates a 3D model of uterus to facilitate treatment in patients with symptomatic uterine fibroids
A Digital Publication for the Practicing Medical Specialist, Industry Executive, & Investor

Nesa Medtech advises their novel SaMD technology generates a 3D model of uterus to facilitate treatment in patients with symptomatic uterine fibroids
Medical Device News Magazine uses cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Google Tag Manager simplifies the management of marketing tags on your website without code changes.
You can find more information in our Cookie Policy: Medical Device NewsMagazine and PRIVACY.